The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Survival after lumpectomy and mastectomy for early stage invasive breast cancer: The effect of age and hormone receptor status
Open accessAbstract
BACKGROUND: Randomized clinical trials (RCT) have demonstrated equivalent survival for breast‐conserving therapy with radiation (BCT) and mastectomy for early‐stage breast cancer. A large, population‐based series of women who underwent BCT or mastectomy was studied to observe whether outcomes of RCT were achieved in the general population, and whether survival differed by surgery type when stratified by age and hormone receptor (HR) status. METHODS: Information was obtained regarding all women diagnosed in the state of California with stage I or II breast cancer between 1990 and 2004, who were treated with either BCT or mastectomy and followed for vital status through December 2009. Cox proportional hazards modeling was used to compare overall survival (OS) and disease‐specific survival (DSS) between BCT and mastectomy groups. Analyses were stratified by age group (< 50 years and ≥ 50 years) and tumor HR status. RESULTS: A total of 112,154 women fulfilled eligibility criteria. Women undergoing BCT had improved OS and DSS compared with women with mastectomy (adjusted hazard ratio for OS entire cohort = 0.81, 95% confidence interval [CI] = 0.80‐0.83). The DSS benefit with BCT compared with mastectomy was greater among women age ≥ 50 with HR‐positive disease (hazard ratio = 0.86, 95% CI = 0.82‐0.91) than among women age < 50 with HR‐negative disease (hazard ratio = 0.88, 95% CI = 0.79‐0.98); however, this trend was seen among all subgroups analyzed. CONCLUSIONS: Among patients with early stage breast cancer, BCT was associated with improved DSS. These data provide confidence that BCT remains an effective alternative to mastectomy for early stage disease regardless of age or HR status. Cancer 2013. © 2012 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Socioeconomic status and breast cancer incidence in California for different race/ethnic groups
Yost, K., Perkins, C., Cohen, R., Morris, C., & Wright, W. (2001) · Cancer Causes & Control · doi:10.1023/a:1011240019516 · Cited by 965
Nguyen, P. L., Taghian, A. G., Katz, M. S., Niemierko, A., Abi Raad, R. F., Boon, W. L., Bellon, J. R., Wong, J. S., Smith, B. L., & Harris, J. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4287 · Cited by 811
Geographic Variation in the Use of Breast-Conserving Treatment for Breast Cancer
Nattinger, A. B., Gottlieb, M. S., Veum, J., Yahnke, D., & Goodwin, J. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261702 · Cited by 542
Katipamula, R., Degnim, A. C., Hoskin, T., Boughey, J. C., Loprinzi, C., Grant, C. S., Brandt, K. R., Pruthi, S., Chute, C. G., Olson, J. E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4225 · Cited by 373
Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer
Morrow, M. (2009) · JAMA · doi:10.1001/jama.2009.1450 · Cited by 333
Studying Radiation Therapy Using SEER-Medicare-Linked Data
Virnig, B. A., Warren, J. L., Cooper, G. S., Klabunde, C. N., Schussler, N., & Freeman, J. (2002) · Medical Care · doi:10.1097/00005650-200208001-00007 · Cited by 286
Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002?
Gross, C. P., Smith, B. D., Wolf, E., & Andersen, M. (2008) · Cancer · doi:10.1002/cncr.23228 · Cited by 246
Jones, H. A., Antonini, N., Hart, A. A. M., Peterse, J. L., Horiot, J.-C., Collin, F., Poortmans, P. M., Oei, S. B., Collette, L., Struikmans, H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.5764 · Cited by 239
Limits of observational data in determining outcomes from cancer therapy
Giordano, S. H., Kuo, Y., Duan, Z., Hortobagyi, G. N., Freeman, J., & Goodwin, J. S. (2008) · Cancer · doi:10.1002/cncr.23452 · Cited by 206
Jagsi, R., Abrahamse, P., Hawley, S. T., Graff, J. J., Hamilton, A. S., & Katz, S. J. (2012) · Cancer · doi:10.1002/cncr.26295 · Cited by 191
Trends in Racial and Age Disparities in Definitive Local Therapy of Early-Stage Breast Cancer
Freedman, R. A., He, Y., Winer, E. P., & Keating, N. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9234 · Cited by 159
Geographic proximity to treatment for early stage breast cancer and likelihood of mastectomy
Boscoe, F. P., Johnson, C. J., Henry, K., Goldberg, D. W., Shahabi, K., Elkin, E. B., Ballas, L., & Cockburn, M. (2011) · The Breast · doi:10.1016/j.breast.2011.02.020 · Cited by 106
Gilligan, M. A., Kneusel, R. T., Hoffmann, R. G., Greer, A. L., & Nattinger, A. B. (2002) · Medical Care · doi:10.1097/00005650-200203000-00002 · Cited by 101
Keegan, T. H. M., Quach, T., Shema, S. J., Glaser, S. L., & Gomez, S. L. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-603 · Cited by 99
Self-citationSmith, G. L., Shih, Y. T., Xu, Y., Giordano, S. H., Smith, B. D., Perkins, G. H., Tereffe, W., Woodward, W. A., & Buchholz, T. A. (2009) · Cancer · doi:10.1002/cncr.24741 · Cited by 94
Factors associated with surgical options for breast carcinoma
Chagpar, A. B., Studts, J. L., Scoggins, C. R., Martin, R. C. G., Carlson, D. J., Laidley, A. L., El‐Eid, S. E., McGlothin, T. Q., Noyes, R. D., & McMasters, K. M. (2006) · Cancer · doi:10.1002/cncr.21728 · Cited by 92
Albain, K. S., Green, S., Lichter, A. S., Hutchins, L. F., Wood, W. C., Henderson, I. C., Ingle, J. N., O’Sullivan, J. M., Osborne, C. K., & Martino, S. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.11.3009 · Cited by 89
van der Sangen, M. J. C., van de Wiel, F. M. M., Poortmans, P. M., Tjan‐Heijnen, V. C. G., Nieuwenhuijzen, G. A. P., Roumen, R. M. H., Ernst, M. F., Nolthenius-Puylaert, M. C. B. J. E. T., & Voogd, A. C. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1110-x · Cited by 86
Itakura, K., Lessing, J. N., Sakata, T., et al. (2011) · Clinical Breast Cancer · doi:10.3816/cbc.2011.n.006 · Cited by 43
Worni, M., Akushevich, I. V., Gloor, B., Scarborough, J., Chino, J., Jacobs, D. O., Hahn, S. M., Clary, B. M., Pietrobon, R. S., & Shah, A. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2088-2 · Cited by 43
Cited by
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz173 · Cited by 2,214
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rutgers, E., Zackrisson, S., & Cardoso, F. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv298 · Cited by 1,597
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Moran, M. S., Abraham, J., Aft, R., Agnese, D., Allison, K. H., Anderson, B., Burstein, H. J., Chew, H., Dang, C., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0030 · Cited by 951
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Senkus, E., Kyriakides, S., Penault-Llorca, F., Poortmans, P., Thompson, A., Zackrisson, S., & Cardoso, F. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt284 · Cited by 479
Metadata
- Authors
- Hwang, E. S., Lichtensztajn, D. Y., Gomez, S. L., Fowble, B., & Clarke, C. A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2013-01-28
- Volume
- 119
- Issue
- 7
- Pages
- 1402-1411
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2067115868
- Cited by
- 258
- References
- 20
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.